1. Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis
   M. Almada et al, 2017, Apoptosis CrossRef
2. Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway
   Yu Fang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. Axis of serotonin -pERK-YAP in liver regeneration
   Yu Fang et al, 2018, Life Sciences CrossRef
4. Structural and functional interaction of Δ9-tetrahydrocannabinol with liver fatty acid binding protein (FABP1)
   Huan Huang et al, 2018, Biochemistry CrossRef
5. Role of cyclin‐dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway
   Shen Shen et al, 2019, Hepatol Res CrossRef
6. Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography–Mass Spectrometry
   Lina Zhou et al, 2012, J. Proteome Res. CrossRef
7. Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β
   Hye-Won Jung et al, 2014 CrossRef
8. Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma
   CHENGZHI XIE et al, 2015 CrossRef
9. Endocannabinoid signaling in liver pathologies
   Bostjan Humar et al, 2015 CrossRef
10. Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
    CHAO MA et al, 2016 CrossRef
11. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
    Alina L. Capatina et al, 2020 CrossRef
12. The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells
    Mikhail G. Akimov et al, 2024, IJMS CrossRef